Table 1 Clinical data and statistical analysis results of 121 patients.
Clinical features | Benign | Malignant | P-value | |
|---|---|---|---|---|
Sex | 0.87 | |||
Male | 32 | 29 | ||
Female | 29 | 31 | ||
Age | 59 | 61 | 0.54 | |
BMI (kg/m2) | 22.55 ± 2.84 | 22.20 ± 2.93 | 0.199 | |
Type | < 0.05 | |||
MD-IPMNs | 12 | 39 | ||
BD-IPMNs | 44 | 9 | ||
MX-IPMNs | 5 | 12 | ||
Position | 0.18 | |||
Head | 28 | 37 | ||
Neck, body and tail | 27 | 23 | ||
All | 6 | |||
Size | < 0.05 | |||
< 3 cm | 46 | 26 | ||
> 3 cm | 15 | 44 | ||
Cystic solid | < 0.05 | |||
Cystic | 52 | 28 | ||
Solid | 4 | 18 | ||
Both | 5 | 14 | ||
Single or multiple | 0.304 | |||
Single | 50 | 50 | ||
Multiple | 11 | 10 | ||
Lymph node involvement | 0.904 | |||
Not involved | 36 | 38 | ||
Involved | 25 | 22 | ||
Pancreatic duct dilation | 0.627 | |||
No | 23 | 14 | ||
Yes | 38 | 46 | ||
Neutrophil/lymphocyte ratio | 2.25 ± 1.17 | 3.13 ± 2.43 | 0.96 | |
Tumour markers | CA199 (U/ml) | 9.48 | 41.33 | < 0.05 |
CA125 (U/ml) | 8.92 | 13.13 | < 0.05 | |
CEA (ng/ml) | 2.23 | 2.85 | 0.649 | |
CA724 (U/ml) | 6.28 | 6.53 | 0.207 | |
CA242 (U/ml) | 8.33 | 30.5 | 0.915 | |
Total bilirubin (µmol/l) | 11.9 | 15.1 | < 0.05 | |
Alkaline phosphatase (U/ml) | 75.5 | 99.4 | < 0.05 | |
\(\gamma\)-ggtt (U/l) | 21.7 | 27.8 | < 0.05 | |
Diabetes | < 0.05 | |||
No | 53 | 43 | ||
Yes | 8 | 17 | ||
Chronic pancreatitis | 0.71 | |||
No | 53 | 55 | ||
Yes | 8 | 5 | ||
Symptom | 0.24 | |||
No | 24 | 19 | ||
Yes | 37 | 41 |
